viernes, 11 de abril de 2025

Baricitinib in early polymyalgia rheumatica (BACHELOR): a randomised, double-blind, placebo-controlled, parallel-group trial

https://www.thelancet.com/journals/lanrhe/article/PIIS2665-9913(24)00270-4/abstract?utm_campaign=update-lanrhe&utm_medium=email&dgcid=hubspot_update_feature_updatealerts_lanrhe&_hsenc=p2ANqtz-88XttwKm17rbERak2CW4jpYLPBqVDciaOGltHeeQiFRb9P6Ppc6wKXOomIkTfpqQ6m3nx5zI9Gew2IiL8nhfxQxjiPWw&_hsmi=355942872&utm_content=355727255&utm_source=hs_email

No hay comentarios:

Publicar un comentario